Introduction
You’re sitting across from an investor. She slides a term sheet across the table. $3.5M pre-money valuation.
Your heart races. Is that good? Is that fair? How do you even know?
You Google “startup valuation formula” and spend the next hour reading about DCF models, comparable company analysis, and exit multiples. Your brain hurts. None of it makes sense for a company with $0 in revenue.
Here’s what nobody tells you: Valuation for early-stage companies isn’t formula-based. It’s market-based.
Investors aren’t running complex financial models. They’re looking at what similar companies raised at, adjusting for your specific strengths and weaknesses, and offering you a number.
Understanding this process—really understanding it—changes how you negotiate, how you make decisions, and ultimately, how much equity you keep.
Section 1: How Young Companies Actually Get Valued
If your company has:
- No revenue
- Limited traction
- Unproven market
- A team nobody’s heard of
…then traditional valuation methods (DCF, venture capital method) are useless. They’re based on financial projections. You don’t have those yet.
So, investors use something called the Scorecard Method.
Here’s how it works:
Step 1: Find market comparables
Investors identify 5–10 similar companies in your geography, at your stage, solving similar problems. They ask: “What did they raise at?”
Example: Other seed-stage SaaS companies in East Africa: average $2–3M pre-money valuation. That’s your anchor point.
Step 2: Adjust for your specific situation
Then they ask: “How is this founder different?”
Adjustments up:
Star team (founder shipped products before, or worked at Google, Airbnb, etc.)
Exceptional traction (100% month-on-month growth, high retention)
Clear market opportunity (solving a real problem, big TAM)
Defensible product (patents, network effects, unique insight)
Adjustments down:
First-time founder
Weak traction
Crowded market
Product isn’t differentiated
Step 3: Land on a number
If the comparable is $2.5M and your team is solid but unproven, maybe you land at $2M. If your product is growing 20% Month on Month, maybe $3.5M.
That’s your valuation.
Is it precise? No. Is it based on assumptions? Yes. But it’s how the market actually works.
Section 2: Why ‘Price’ and ‘Value’ Aren’t the Same Thing
Here’s where most founders get blindsided.
Price = The amount an investor offers right now, to invest in your company today.
Price is influenced by:
Market sentiment (Is it a bull market or bear market?)
Investor FOMO (Are multiple investors competing?)
Fund deployment pressure (Does this investor have dry powder they need to deploy?)
Negotiating power (Did you leverage competitive term sheets?)
Your willingness to accept (Did you research comparable valuations?)
Value = What your company is actually capable of becoming.
Value is based on:
Your team’s ability to execute
The market opportunity (real, not hype)
Your competitive advantages
Market tailwinds
Your product-market fit signals
Here’s the problem: Price and value often diverge.
In 2021, many early-stage companies got offered high prices because investors were feeling bullish, money was cheap, and there was FOMO everywhere. But many of those companies didn’t have the value to back it up. No revenue. Questionable product-market fit. Unproven team.
What happened? Many of those companies raised at high valuations, couldn’t hit the milestones that valuation implied, and got hammered in down rounds in 2022–2023.
Your job as a founder:
Understand what your company’s value is (realistic assessment)
Research what the price is in your market right now (comparable valuations)
Question if they match
Negotiate based on that gap
If an investor offers you a price that’s way above comparable valuations, that’s not a win. That’s a trap. Because you’ll be expected to hit growth numbers that justify it.
Section 3: How Valuation Cascades into Everything Downstream
Here’s why this matters enough to spend a week on it: Your valuation today determines:
- Your equity dilution (now and future rounds)
Raise $500K at $2M pre-money valuation = 20% dilution
Raise $500K at $5M pre-money valuation = 9% dilution
Same capital, different ownership stake. And you keep that difference through Series A, Series B, and beyond.
- Expectations for your next round
Raise at $10M pre-money as a seed-stage company, and your Series A investors expect you’ve hit massive milestones—$500K ARR, proven unit economics, enterprise customers. Can’t hit those? You’ll get a “down round”—Series A at a lower valuation than your seed. Psychologically brutal. Founder motivation tank.
Raise at $3M pre-money, and your Series A expectations are different (and achievable).
- Your exit value
Early valuations don’t determine exit values, but they set the tone. If your seed valuation was too high relative to your progress, future investors will be skeptical. If it was reasonable, they’ll see a founder who knows how to raise smartly.
- Founder motivation
Raise at a valuation where your equity still matters, you stay hungry. Raise at a valuation that’s disconnected from reality, you either burn out trying to hit impossible targets, or you become cynical about the whole thing.
Section 4: What Actually Goes Wrong (and How to Avoid It)
Mistake 1: Accepting a valuation without understanding the math
Don’t do this. Ask the investor: “How did you arrive at this number?” If they can’t articulate their thinking, that’s a red flag.
Mistake 2: Confusing ‘high valuation’ with ‘win’
High valuation = high expectations. If you can’t deliver, it’s not a win.
Mistake 3: Ignoring future rounds
Don’t just think about this round. Think about Series A, B, exit. How does this valuation cascade?
Mistake 4: Not researching comparable valuations
Do the work. Find 5–10 similar companies. What did they raise at? Talk to other founders who’ve raised recently. Know your market.
Section 5: How to Navigate Your Valuation Conversation
When an investor proposes a number:
Ask how they got there. “Can you walk me through your thinking?” Their answer tells you everything.
Research comparable valuations before you go in. You should have a range, not a target number.
Know your value. Separate valuation from your belief in your company. You can believe deeply in your company and still negotiate valuation rationally.
Consider total economics. Valuation matters, but so do liquidation preferences, anti-dilution clauses, board seats, and investor support. Don’t fixate on valuation alone.
Remember: You’re not trying to “win” the negotiation. You’re trying to find a number that keeps both you and the investor motivated for the long haul.
Closing
Your valuation isn’t a formula. It’s not magic. It’s market comparables plus your specific strengths and weaknesses.
Understand it. Question it. Make sure it reflects reality, not just market hype.
Because next week, we’re getting into the clauses—liquidation preferences, anti-dilution, everything that actually determines your equity in an exit.
And those clauses matter way more if your valuation is realistic to start with.
Add a Comment